Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Synthesis and Preliminary Evaluation of N-Oxide Derivatives for the Prevention of Atherothrombotic Events

Full text
Author(s):
Rosseto, Leandro Augusto [1] ; Lopes Pires, Maria Elisa [2] ; Bolognesi Melchior, Aylime Castanho [1] ; Bosquesi, Priscila Longhin [1] ; Pavan, Aline Renata [1] ; Marcondes, Sisi [2] ; Chung, Man Chin [1] ; dos Santos, Jean Leandro [1]
Total Authors: 8
Affiliation:
[1] Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, BR-14801902 Araraquara, SP - Brazil
[2] Univ Estadual Campinas, Dept Farmacol, Fac Ciencias Med, UNICAMP, BR-13083887 Campinas, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: Molecules; v. 20, n. 10, p. 18185-18200, OCT 2015.
Web of Science Citations: 9
Abstract

Thrombosis is the main outcome of many cardiovascular diseases. Current treatments to prevent thrombotic events involve the long-term use of antiplatelet drugs. However, this therapy has several limitations, thereby justifying the development of new drugs. A series of N-oxide derivatives (furoxan and benzofuroxan) were synthesized and characterized as potential antiplatelet/antithrombotic compounds. All compounds (3a,b, 4a,b, 8a,b, 9a,b, 13a,b and 14a,b) inhibited platelet aggregation induced by adenosine-5-diphosphate, collagen, and arachidonic acid. All compounds protected mice from pulmonary thromboembolism induced by a mixture of collagen and epinephrine; however, benzofuroxan derivatives (13a,b and 14a,b) were the most active compounds, reducing thromboembolic events by up to 80%. N-oxide derivative 14a did not induce genotoxicity in vivo. In conclusion, 14a has emerged as a new antiplatelet/antithrombotic prototype useful for the prevention of atherothrombotic events. (AU)

FAPESP's process: 10/02774-5 - Design and synthesis of new acetyl salicilic acid hybrid analogues useful for treatment and prevention of atherothrombosis
Grantee:Leandro Augusto Rosseto
Support Opportunities: Scholarships in Brazil - Scientific Initiation